IL1B and metabolic dysfunction-associated steatohepatitis: Thus both systemic circulation-derived and the locally released IL-1β contributes with several mechanisms to the pathophysiology of NASH, such as promotion of steatosis11, interference with insulin signaling12, stimulation of hepatic stellate cells to produce fibrotic proteins13, and by promotion of neutrophil recruitment14.